Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.51
Delayed Data
As of Jun 22
 +0.01 / +0.67%
Today’s Change
1.28
Today|||52-Week Range
4.47
-13.22%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close1.50
Today’s open1.50
Day’s range1.50 - 1.57
Volume50,873
Average volume (3 months)101,823
Market cap$17.2M
Data as of 3:59pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+44.29%
Earnings growth (this year)+78.97%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book0.79

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...-0.01-1.54%
ACSTAcasti Pharma Inc-0.03-4.40%
HTBXHeat Biologics Inc-0.13-5.28%
KTOVKitov Pharma Ltd+0.09+3.49%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$0.00
Annual profit (last year)-$7.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts